Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.16p
   
  • Change Today:
      0.033p
  • 52 Week High: 7.76
  • 52 Week Low: 1.59
  • Currency: UK Pounds
  • Shares Issued: 333.40m
  • Volume: 307,994
  • Market Cap: 7.19m
  • RiskGrade: 328

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-22 Interim n/a (1.83) (0.58)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 0.15 (7.00) (4.75)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.08 (7.96) (5.19)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.08 (6.74) (3.99)p n/a n/a n/a n/a 0.0%
31-Dec-20 0.13 (7.25) 3.43p 3.9 n/a n/a n/a 0.0%
31-Dec-21 0.12 (8.94) 3.25p 2.0 n/a -5% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 3.89 2.03 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Immupharma Market Data

Currency UK Pounds
Share Price 2.16p
Change Today 0.033p
% Change 1.53 %
52 Week High 7.76
52 Week Low 1.59
Volume 307,994
Shares Issued 333.40m
Market Cap 7.19m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
75.55% above the market average75.55% above the market average75.55% above the market average75.55% above the market average75.55% above the market average
83.05% above the sector average83.05% above the sector average83.05% above the sector average83.05% above the sector average83.05% above the sector average
Price Trend
86.8% below the market average86.8% below the market average86.8% below the market average86.8% below the market average86.8% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Income Not Available
Growth
40.71% below the market average40.71% below the market average40.71% below the market average40.71% below the market average40.71% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average

Immupharma Dividends

No dividends found

Trades for 31-Mar-2023

Time Volume / Share Price
16:05 25,000 @ 1.96p
15:52 40,000 @ 1.97p
15:51 40,000 @ 1.92p
15:27 34,613 @ 1.96p
13:23 15,000 @ 1.93p

Immupharma Key Personnel

CEO Dimitri Dimitriou

Top of Page